NSN 6505-01-379-5446
Part Details | NIFEDIPINE EXTENDED-RELEASE TABLETS
6505-01-379-5446
Alternate Parts: NDC00591319401, NDC00591-3194-01, AFEDITAB CR, NDC52427049501, NDC52427-0495-01, ADALAT CC, NDC00378048101, NDC00378-0481-01, NDC00378036001, NDC00378-0360-01, NDC10370067801, NDC10370-0678-01, NDC68682010610, NDC68682-0106-10, 6505-01-379-5446, 01-379-5446, 6505013795446, 013795446
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | SEP 02, 1993 | 01-379-5446 | 45547 ( NIFEDIPINE EXTENDED-RELEASE TABLETS ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-379-5446
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00591-3194-01 | 6LMB8 | ACTAVIS PHARMA, INC. |
| AFEDITAB CR | 6LMB8 | ACTAVIS PHARMA, INC. |
| NDC52427-0495-01 | 6SU97 | ALMATICA PHARMA INC. |
| ADALAT CC | 6SU97 | ALMATICA PHARMA INC. |
| NDC00378-0481-01 | 3KJG9 | MYLAN PHARMACEUTICALS INC. |
| NDC00378-0360-01 | 3KJG9 | MYLAN PHARMACEUTICALS INC. |
| NDC10370-0678-01 | 0VZ14 | PAR PHARMACEUTICAL, INC.DBA PAR PHARMACEUTICAL |
| NDC68682-0106-10 | 3AWU3 | VALEANT PHARMACEUTICALSINTERNATIONAL CORPORATION |
Technical Data | NSN 6505-01-379-5446
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | CV60.000 MILLIGRAMS NIFEDIPINE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| THERAPEUTIC EQUIVALENT | ADALAT CC BY ALMATICA PHARMA INC. |
| SPECIAL FEATURES | INDICATED FOR THE MANAGEMENT OF CHRONIC STABLE ANGINA (EFFORT-ASSOCIATED ANGINA) AND FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE. STORE AT 20 TO 25 C (68 TO 77 F) ?SEE USP CONTROLLED ROOM TEMPERATURE| PROTECT FROM MOISTURE, HUMIDITY, AND LIGHT. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | NIFEDIPINE EXTENDED-RELEASE TABLETS 60MG 24 HOURS 100S BT |
